Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination and Alternating Nucleoside Therapy with or without Nevirapine in Advanced HIV
NCT00000781Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 2 trial of nevirapine, zidovudine, zalcitabine, didanosine in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
nevirapinezidovudinezalcitabinedidanosine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00000781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000781.